For patients with inflammatory bowel disease (IBD), serum 25-hydroxyvitamin D (25[OH]D) may serve as a biomarker for disease activity, according to a study published online Sept. 10 in the Journal of Clinical Medicine.
❓ Unknown
Serum 25(OH)D as a Potential Biomarker for Disease Activity in Inflammatory Bowel Disease
Just now
October 1, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
A study published in the Journal of Clinical Medicine suggests that serum 25-hydroxyvitamin D (25[OH]D) could be an important biomarker for assessing disease activity in patients with inflammatory bowel disease (IBD). This research may have implications for healthcare practices in Iran, particularly in managing chronic diseases. Understanding vitamin D levels could enhance patient care and treatment outcomes.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
13 min ago •
Gap in International Human Rights Law Regarding Migrant Entry Highlighted in New Analysis
13 min ago •
AI Scientist Develops New Biological Discoveries Autonomously
13 min ago •
Combination Therapy Shows Promise for Treating Aggressive Kidney Cancer
16 min ago •
Urban Investment Development: A Path to Reducing Municipal Dependency on Unstable Revenues
17 min ago •